It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

被引:5
|
作者
Oberle, Megan M. [1 ,2 ]
Kelly, Aaron S. [1 ,2 ]
机构
[1] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Ctr Pediat Obes Med, Minneapolis, MN 55455 USA
来源
关键词
GLP-1 receptor agonists; pedatrics; type; 2; diabetes; obesity; weight management; adolescents; DOUBLE-BLIND; WEIGHT-LOSS; LIRAGLUTIDE; PLACEBO; SAFETY; PHARMACOKINETICS; MANAGEMENT; MELLITUS; THERAPY; OBESITY;
D O I
10.3389/fendo.2019.00738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
    Hansen, K. B.
    Knop, F. K.
    Holst, J. J.
    Vilsboll, T.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (08) : 1154 - 1160
  • [2] Glucagon-like Peptide-1 Receptor Agonists Prescribing Patterns in Youth with Type 2 Diabetes
    Bensignor, Megan
    Kelly, Aaron
    Wolfe, Jack
    Rudser, Kyle
    Arslanian, Silva
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 81 - 82
  • [3] Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
    Edwards, C. M. B.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 198 - 201
  • [4] Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
    Gentilella, Raffaella
    Pechtner, Valeria
    Corcos, Antonella
    Consoli, Agostino
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [5] Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 407 - 414
  • [6] Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
    Tran, Kelvin Lingjet
    Park, Young In
    Pandya, Shalin
    Muliyil, Navin John
    Jensen, Brandon David
    Huynh, Kovin
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 178 - 187
  • [7] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy, 2019, 36 : 798 - 805
  • [8] The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Lu, Ju-Ming
    ADVANCES IN THERAPY, 2019, 36 (04) : 798 - 805
  • [9] Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
    Ji, Qiuhe
    CLINICAL THERAPEUTICS, 2017, 39 (06) : 1244 - 1264
  • [10] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (03): : 359 - 360